The NSF IUSE:EHR Program invites proposals which address current challenges and opportunities facing undergraduate STEM education. In addition, proposals that anticipate new structure and functions of undergraduate learning and teaching are also encouraged to be submitted for consideration. The goal of the IUSE:EHR Program is to facilitate the provision of highly effective, evidence-based teaching and learning experiences for undergraduate students in STEM courses.
The National Institutes of Health (NIH) has made changes to its policies on studies involving human subjects that may impact current agency-funded research and future proposals.
Faculty should take the time to answer the following questions about their current or proposed research:
- Does the study involve human subjects?
- Are the participants prospectively assigned to an intervention?
- Is the study designed to evaluate the effect of the intervention on the participants?
- Is the effect that will be evaluated a health-related biomedical or behavioral outcome?
Faculty who answer yes to all four questions has research that meets the NIH definition of a clinical trial.
NIH has a web page clarifying their clinical trial definition and providing case studies and FAQs about clinical trials.
Faculty whose research meets the NIH definition of a clinical trial should become familiar with the new PHS Human Subject and Clinical Trail Information form and the FORMS-E application package, which will replace FORMS-D.
All the information you need to know can be found on the Clinical Trial Requirements for NIH Grantees and Contractors web page. Other helpful resources can be found in the NIH Guide to Grants and Contracts and the NIH Extramural Nexus.
One of NIH’s primary objectives is to strengthen the biomedical workforce. In order to provide greater support for the next generation of biomedical researchers, NIH has announced the Next Generation Researchers Initiative, whereby the agency is taking a multi-pronged approach that will both increase the number of early-stage and mid-career researchers and assist in stabilizing the trajectory of scientists. To carry out this initiative, NIH will:
- Commit approximately $210 million this year to this initiative. The funds will increase to about $1.1 billion dollars after five years to support promising early-stage and mid-career investigators
- Assess implementation effectiveness by creating an internal database and tracking the impact of NIH funding decisions for early- and mid-career investigators with fundable scores
- Emphasize more heavily the NIH funding mechanisms focused on early- and mid-career investigators
- Strive to fund most early-career investigators with R01 equivalent applications with scores in the top 25th percentile
- Encourage multiple approaches to develop and test metrics to evaluate the effectiveness of NIH’s research portfolio and assess the impact of NIH grant support on scientific progress
Applicants are not required to take any additional steps to be eligible for this funding consideration. At the start of this fiscal year, the NIH institute or center funding a grant will give applicants special consideration for support if they are: an early-stage investigator (10 years or less after completing your terminal degree/medical residency, have not received a substantial independent NIH research award, and received a score in the top 25th percentile) or a mid-career investigator (within 10 years of receiving first NIH R01 equivalent, scores in the 25th percentile, and are either at risk of losing all support or is a promising investigator supported by a single ongoing award.